240 likes | 245 Vues
Endocrine Combinations in HR-Positive MBC: The Future Is Now. Program Overview. Treatment Challenges in Postmenopausal Patients With HR+ Advanced Disease. Algorithm for Management of Postmenopausal ER+ MBC. Visceral Crisis. Combined ET Results.
E N D
Endocrine Combinations in HR-Positive MBC: The Future Is Now
Treatment Challenges in Postmenopausal Patients With HR+ Advanced Disease
Phase 2 FIRST Trial: Fulvestrant vs Anastrozole for Advanced Breast Cancer
PALOMA-1: All-Causality AEs Occurring in ≥10% of Patients (Safety Population)
BELLE-2: Buparlisib Plus Fulvestrant in Advanced HR+ Disease